Table 1.
Demographic | Tolcapone First (n = 14) |
Placebo First (n = 14) |
Total (n = 28) |
---|---|---|---|
Average Age (SD) | 62.7 (6.7) | 63.6 (9.1) | 63.1 (7.8) |
Average Age of Onset (SD) | 54.2 (3.0) | 52.5 (9.0) | 53.3 (6.7) |
Sex (M/F) | 6/8 | 8/6 | 14/14 |
Race (white/other) | 13/1 (African American) | 12/2 (Asian-Indian) | 25/3 (one African American, two Asian-Indian |
Average Education Years (SD) | 17.4 (1.6) | 16.8 (2.0) | 17.1 (1.8) |
Average MDRS Baseline (SD) | 109.2 (23.3) | 105.0 (27.1) | 107.1 (24.8) |
Site (NINDS/Columbia) | 4/10 | 5/9 | 9/19 |
SD, standard deviation; M, male; f, female; NINDS, National Institute of Neurological Disorders and Stroke.